LCN2 and polycystic ovary syndrome: Since the first decade of the 21st century, LCN2 has gathered a growing interest, due to its potential role as a biomarker for PCOS; nevertheless, the results of studies aiming to confirm this hypothesis remain ambiguous [35,177,181,182,183,184,185,186].